Clinical Trials
516 trialsContinuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
National Institutes of Health Clinical Center (CC)
CAR-Lille
University Hospital, Lille
xDRIVE for Florida-based Cancer Patients
First Ascent Biomedical Inc.
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
Servier
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
National Hospital Organization Nagoya Medical Center
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
National Institutes of Health Clinical Center (CC)
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Feasibility Neurocognitive Outcome After Transplant
Stanford University
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
University of Kansas Medical Center
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Genmab
APEX
Cogent Biosciences, Inc.
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
AbbVie
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
National Institutes of Health Clinical Center (CC)
PROVIDENCE
AbbVie
Case-Control Study of Pesticides and Childhood Leukemia
National Institutes of Health Clinical Center (CC)
Longitudinal Studies of Patient With FPDMM
National Institutes of Health Clinical Center (CC)
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
St. Jude Children's Research Hospital
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
St. Jude Children's Research Hospital
Durvalumab and Tremelimumab for Pediatric Malignancies
AstraZeneca
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers
City of Hope Medical Center
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
PRAGMATIC
The University of Queensland
QUATRO-APL
Quetzal Therapeutics
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
St. Jude Children's Research Hospital
Massage Impact on Sleep in Pediatric Oncology
Children's Hospital of Philadelphia
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Calibr, a division of Scripps Research
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders
Celgene
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
University of Southern California
UR-GOAL RCT
University of Rochester
LAUREL
Inmune Bio, Inc.
ASAP
Avera McKennan Hospital & University Health Center
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
CLOVER-WaM
Cellectar Biosciences, Inc.
ACCESS
Center for International Blood and Marrow Transplant Research
OPTIC
Takeda
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Vanda Pharmaceuticals
Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber
Henan University
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Astellas Pharma Inc
Discontinuation Study
University College Cork